Edition:
United States

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

20.14USD
20 Apr 2018
Change (% chg)

$0.02 (+0.10%)
Prev Close
$20.12
Open
$19.97
Day's High
$20.46
Day's Low
$19.87
Volume
22,776
Avg. Vol
28,404
52-wk High
$24.00
52-wk Low
$15.01

Latest Key Developments (Source: Significant Developments)

Optinose Reports Q4 Loss Per Share $0.64
Tuesday, 13 Mar 2018 07:00am EDT 

March 13 (Reuters) - Optinose Inc ::OPTINOSE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS.Q4 LOSS PER SHARE $0.64.Q4 EARNINGS PER SHARE VIEW $-0.50 -- THOMSON REUTERS I/B/E/S.EXPECTS TO INITIATE A PHASE 3B TRIAL OF XHANCE AS A TREATMENT FOR CHRONIC SINUSITIS IN Q4 OF 2018.OPTINOSE - BELIEVES CURRENT CASH, CASH EQUIVALENTS SUFFICIENT TO FUND OPERATIONS AND DEBT SERVICE OBLIGATIONS THROUGH END OF 2019.  Full Article

OptiNose Inc Qtrly Net Loss ‍$4.23 Per Share​
Monday, 27 Nov 2017 04:23pm EST 

Nov 27 (Reuters) - Optinose Inc ::OPTINOSE INC - QTRLY NET LOSS ‍$4.23 PER SHARE​.  Full Article

Optinose Inc shares open at $20.00 in debut on the NASDAQ, up 25 pct versus IPO price
Friday, 13 Oct 2017 10:29am EDT 

Oct 13 (Reuters) - :Optinose Inc shares open at $20.00 in debut on the NASDAQ versus IPO price of $16.00 per share.  Full Article

  • Previous
  • Next

OptiNose Inc News

BRIEF-Optinose Announces $100 Mln Debt Financing From Athyrium Capital Management

* OPTINOSE ANNOUNCES $100 MILLION DEBT FINANCING FROM ATHYRIUM CAPITAL MANAGEMENT Source text for Eikon: Further company coverage:

» More OPTN.OQ News

Earnings vs. Estimates

» More Financials